Showing results (281-290 of 395) with videos related to

Sort By:
Pageof 40
Psychiatry and Clinical Neurosciences|November 1, 2024
Risk of subsequent Parkinson's disease among patients with bipolar disorder or major depression: A nationwide longitudinal study in TaiwanMao-Hsuan Huang, Chih-Ming Cheng, Ju-Wei Hsu, et al.
Acta Psychiatrica Scandinavica|October 11, 2022
A longitudinal study of the association between pro-inflammatory cytokines and mood symptoms in bipolar disorderMao-Hsuan Huang, Yee-Lam E Chan, Mu-Hong Chen, et al.
Journal of the Chinese Medical Association : JCMA|July 19, 2018
The Shipai cohort for cardiovascular metabolic risk factors and outcome study - Design and preliminary resultsShu-Chiung Chiang, Ching-Fai Kwok, Tzeng-Ji Chen, et al.
Acta Psychiatrica Scandinavica|October 30, 2025
Risk of Stroke in Patients With Schizophrenia, Bipolar Disorder, and Major Depressive Disorder: A Cohort Study of 183,504 SubjectsMao-Hsuan Huang, Chih-Ming Cheng, Ju-Wei Hsu, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|May 12, 2017
Dose-Related Effects of Adjunctive Ketamine in Taiwanese Patients with Treatment-Resistant DepressionTung-Ping Su, Mu-Hong Chen, Cheng-Ta Li, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|November 30, 2018
Correction: Dose-Related Effects of Adjunctive Ketamine in Taiwanese Patients with Treatment-Resistant DepressionTung-Ping Su, Mu-Hong Chen, Cheng-Ta Li, et al.
The Journal of Clinical Psychiatry|December 29, 2007
Adiponectin as a potential biomarker for the metabolic syndrome in Chinese patients taking clozapine for schizophreniaYa Mei Bai, Jen-Yeu Chen, Wei-Shiung Yang, et al.
Journal of the Chinese Medical Association : JCMA|August 13, 2013
Taiwan consensus of pharmacological treatment for bipolar disorderYa-Mei Bai, Ching-Jui Chang, Shang-Ying Tsai, et al.
Pageof 40